Delivery Order SPE2DB22D9309-SPE2DB25FAF58
- Not listed
- The Defense Logistics Agency awarded a $1,315.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency awarded a delivery order valued at $5,263.24 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits, with an ultimate completion date of August 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract employs firm fixed-price pricing and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,947.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, utilizes a firm fixed-price structure and carries no set-aside designation. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a $6,579.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. This delivery order, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately...
- The Defense Logistics Agency awarded a $6,579.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 26, 2025, for Mitosol 0.2 mg kits, with an ultimate completion date of October 20, 2025. This delivery order was issued without a set-aside designation and represents a continuation of the agency's ongoing pharmaceutical supply needs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime...
- The Defense Logistics Agency (DLA) under the Medical Supply Chain issued a delivery order valued at $7,894.80 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits. The award, made on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at approximately $500 million through...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $1,315.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Mitosol 0.2mg kits, a pharmaceutical product, with a period of performance through April 4, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract 4600082013 with the DLA, valued at up...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. This firm fixed-price delivery order, valued at $1,315.80, was awarded on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis in the federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,263.24 by the Defense Logistics Agency on August 20, 2025, for the supply of Mitosol 0.2 mg kits. The delivery order carries an ultimate completion date of September 11, 2025, and no set-aside designation was used in the procurement. This award represents a continuation of the company's established role as a critical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,789.60 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award was issued on May 12, 2025, with an ultimate completion date of June 3, 2025, and carries no set-aside designation. This delivery order falls under DMS...
- SPE2DB22D9309Indefinite Delivery Contract
- SPE2DB22D9309-SPE2DB25FAF58Delivery Order
The Defense Logistics Agency has awarded a $78,483.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. The contract, issued on September 27, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation. This delivery order represents work performed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.99 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military health facility operations. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company maintains a robust portfolio of pharmaceutical distribution services to Department of Defense healthcare systems nationwide, spanning branded and generic prescription medications, biologics, and medical consumables. Mitosol, an ophthalmic anti-metabolite, is commonly used in ophthalmologic surgical procedures to prevent scarring and enhance surgical outcomes, making this delivery order consistent with the company's mission to supply specialized pharmaceutical products to military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $78.5k | 9/27/25 |